Nasal Spray Vaccines – A Breath of Immunity: An Interview with Dr. Marc-André Langlois

Contenu principal de l'article

Zacharie Saint-Georges

Résumé

Dr. Marc-André Langlois, a cutting-edge virologist, Canada Research Chair in Molecular Virology and Intrinsic Immunity, and Professor in the Department of Biochemistry, Microbiology and Immunology at the University of Ottawa, received 1 million dollars in Canadian Institutes of Health Research (CIHR) funding to develop a nasal spray COVID-19 vaccine. We had the privilege of meeting with him virtually and having a fascinating and informative conversation on the COVID-19 pandemic, vaccines, and its effect on society.

Renseignements sur l'article

Rubrique
Interview
Biographie de l'auteur-e

Omar Dewidar

Omar is a first year student in the Masters of Epidemiology program at the University of Ottawa. He is experienced in conducting systematic reviews and statistical analysis using R. Omar’s research interests include cardiovascular diseases and addressing health inequities in healthcare.

Omar is a devoted volunteer in his community, where he volunteers at the University of Ottawa  Health Institute. He is also an avid athlete, football player and Premiere League fan.